Segueix
Nasim Vahidfar
Nasim Vahidfar
Correu electrònic verificat a sina.tums.ac.ir
Títol
Citada per
Citada per
Any
Theranostic advances in breast cancer in nuclear medicine
N Vahidfar, A Aghanejad, H Ahmadzadehfar, S Farzanehfar, E Eppard
International journal of molecular sciences 22 (9), 4597, 2021
612021
Recent trends in diagnostic biomarkers of tumor microenvironment
P Siminzar, MR Tohidkia, E Eppard, N Vahidfar, A Tarighatnia, ...
Molecular Imaging and Biology 25 (3), 464-482, 2023
562023
Mucin-1 conjugated polyamidoamine-based nanoparticles for image-guided delivery of gefitinib to breast cancer
PN Nabi, N Vahidfar, MR Tohidkia, AA Hamidi, Y Omidi, A Aghanejad
International journal of biological macromolecules 174, 185-197, 2021
462021
An impressive approach in nuclear medicine: theranostics
N Vahidfar, E Eppard, S Farzanehfar, A Yordanova, M Fallahpoor, ...
PET clinics 16 (3), 327-340, 2021
232021
Development and evaluation of a 166holmium labelled porphyrin complex as a possible therapeutic agent
N Vahidfar, AR Jalilian, Y Fazaeli, A Bahrami-Samani, D Beiki, A Khalaj
Journal of Radioanalytical and Nuclear Chemistry 295, 979-986, 2013
222013
Development of radiolanthanide labeled porphyrin complexes as possible therapeutic agents in beast carcinoma xenografts
N Vahidfar, AR Jalilian, Y Fazaeli, A Aghanejad, A Bahrami-Samani, ...
Radiochimica Acta 102 (7), 659-668, 2014
192014
Radiosynthesis and biological evaluation of 166Ho labeled methoxylated porphyrins as possible therapeutic agents
N Vahidfar, AR Jalilian, Y Fazaeli, A Bahrami-Samani, D Beiki, A Khalaj
Journal of Radioanalytical and Nuclear Chemistry 301, 269-276, 2014
192014
Historical review of pharmacological development and dosimetry of PSMA-based theranostics for prostate cancer
N Vahidfar, M Fallahpoor, S Farzanehfar, G Divband, H Ahmadzadehfar
Journal of Radioanalytical and Nuclear Chemistry 322, 237-248, 2019
182019
A review of nuclear medicine approaches in the diagnosis and the treatment of gynecological malignancies
N Vahidfar, S Farzanefar, H Ahmadzadehfar, EN Molloy, E Eppard
Cancers 14 (7), 1779, 2022
162022
177Lu-EDTMP for Metastatic Bone Pain Palliation: A Systematic Review and Meta-Analysis
E Askari, S Harsini, N Vahidfar, G Divband, R Sadeghi
Cancer biotherapy & radiopharmaceuticals 36 (5), 383-390, 2021
162021
Preparation and biodistribution study of a 99mTc-labeled toxic fraction of Iranian mesobuthus eupeus scorpion venom
SP Shirmardi, M Gandomkar, M Shamsaei, MA ZARE, MM GHANADI, ...
IRANIAN JOURNAL OF NUCLEAR MEDICINE 18 (133), 37-44, 2010
142010
Diagnostic Value of Radiolabelled Somatostatin Analogues for Neuroendocrine Tumour Diagnosis: The Benefits and Drawbacks of [64Cu]Cu-DOTA-TOC
N Vahidfar, S Farzanehfar, M Abbasi, S Mirzaei, ES Delpassand, ...
Cancers 14 (8), 1914, 2022
122022
Preparation and validation of [67Ga]Ga-phytate kit and Monte Carlo dosimetry: an effort toward developing an impressive lymphoscintigraphy tracer
Z Bayat, E Saeedzadeh, N Vahidfar, M Sadeghi, S Farzenefar, FJ Daha, ...
Journal of Radioanalytical and Nuclear Chemistry 331 (2), 691-700, 2022
92022
An overview of labeled porphyrin molecules in medical imaging
N Vahidfar, AR Jalilian
Recent Patents Topics Imaging 5, 3-12, 2015
52015
Preparation of a 153Sm-5, 10, 15, 20-tetrakis (4-methoxyphenyl) porphyrin complex as a possible therapeutic agent
N Vahidfar, AR Jalilian, Y Fazaeli, A Bahrami-Samani, D Beiki, A Khalaj
Iran J Nucl Med 23 (2), 65-72, 2015
42015
Discordance between using estimated and measured glomerular filtration rate for drug dosing in kidney transplant recipients
M Nabiee, N Vahidfar, S Dashti-Khavidaki, MR Khatami, M Abbasi, ...
Iranian Journal of Kidney Diseases 15 (3), 213, 2021
32021
Recent Advances of Copper-64 Based Radiopharmaceuticals in Nuclear Medicine
N Vahidfar, MB Kashi, S Afshar, P Sheikhzadeh, S Farzanefar, Y Salehi, ...
Advances in Dosimetry and New Trends in Radiopharmaceuticals, 2024
22024
Impact of attenuation correction, collimator, and iterative reconstruction protocols on 67Ga SPECT/CT quantification
S Rezaei, S Farzanehfar, L Badrzadeh, F Assadi, N Vahidfar, ...
Frontiers in Biomedical Technologies, 2023
22023
Preparation and biological evaluation of a carrier free yttrium labelled porphyrin as a possible agent for targeted therapy of tumor
M Abedi, MR Nabid, S Shirvani-Arani, A Bahrami-Samani, N Vahidfar
Journal of Porphyrins and Phthalocyanines 21 (01), 24-30, 2017
22017
Recent Advances in the Diagnosis of Alzheimer's Disease: A Brief Overview of Tau PET Tracers in Nuclear Medicine
F Aghahosseini, Y Salehi, S Farzanefar, MB Kashi, E Eppard, ...
Current radiopharmaceuticals, 2025
12025
En aquests moments el sistema no pot dur a terme l'operació. Torneu-ho a provar més tard.
Articles 1–20